Sponsor pipeline

Beijing Immunochina Medical Science & Technology Co., Ltd. clinical trial pipeline

Get alerts when Beijing Immunochina Medical Science & Technology Co., Ltd.'s trials change

7 active trials 2 recruiting 4 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Early Phase 1
3
Phase 1
3
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT04440436 Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's… NHL Recruiting 2020-12-08
Phase 1
NCT06718738 Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer Colorectal Cancer (CRC) Recruiting 2024-12-05
NCT07406984 Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of… Adenocarcinoma of Gastric Not Yet Recruiting 2026-02-13
NCT06852573 Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus… Systemic Lupus Erythematosus Not Yet Recruiting 2025-02-28
Early Phase 1
NCT06886919 Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for… Difficult to Treat Systemic Lupus Erythematosus Not Yet Recruiting 2025-03-24
NCT06690359 IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients IgA Nephropathy Not Yet Recruiting 2024-11-26
NCT06691308 WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients Recurrent or Progressive Glioblastoma Not Yet Recruiting 2024-11-18

Disease areas by active trials

Get alerts when Beijing Immunochina Medical Science & Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free